Montes Félix R, Trillos Julio E, Rincón Ismael E, Giraldo Juan C, Rincón José D, Vanegas María V, Charris Hernán
Department of Anesthesiology, Fundación Cardio Infantil - Instituto de Cardiología, Universidad del Rosario, Bogotá, Colombia, South America.
J Clin Anesth. 2002 Aug;14(5):324-8. doi: 10.1016/s0952-8180(02)00367-7.
To compare the recovery characteristics of two widely used anesthetic techniques: remifentanyl-propofol and sevoflurane-fentanyl in a standardized ambulatory population.
Randomized, single-blinded study.
University-affiliated medical center.
50 ASA physical status I and II patients undergoing elective ambulatory otorhinolaryngeal surgery.
Patients were randomized two groups to receive total intravenous anesthesia (TIVA group) with remifentanil and propofol or sevoflurane-fentanyl (SF group). TIVA patients received induction with propofol 1.5 mg/kg intravenously (IV) and remifentanil 0.5 microg/kg IV. The anesthesia was continued with a continuous infusion of propofol 100 microg/kg/min and remifentanil 0.0625-0.25 microg/kg/min. The SF group received, at induction, fentanyl 2 microg/kg followed by propofol 1.5 mg/kg IV. Maintenance was obtained with 1 to 1.5 minimum alveolar concentration of sevoflurane and bolus of fentanyl 1 microg/kg IV as needed.
Early recovery times (eye opening, response to commands, extubation, orientation, operating room stay after surgery, and Aldrete score > or =9) and patient satisfaction were similar between the two groups. Postanesthetic discharge scoring system (PADSS) > or = 9 was significantly shorter for the TIVA group (135.9 +/- 51 vs. 103 +/- 32 min) (p < 0.01) but this difference was not associated with a shorter postanesthesia care unit (PACU) length of stay.
Early recovery times are comparable between total intravenous anesthesia and sevoflurane-based anesthesia. Even though patients in the TIVA group achieved home readiness criteria in a significantly shorter time, this technique does not shorten PACU length of stay, which depends instead on multiple nonmedical and administrative issues.
在标准化的门诊患者群体中比较两种广泛使用的麻醉技术:瑞芬太尼 - 丙泊酚和七氟醚 - 芬太尼的恢复特征。
随机、单盲研究。
大学附属医院医疗中心。
50例美国麻醉医师协会(ASA)身体状况为I级和II级、接受择期门诊耳鼻喉手术的患者。
患者被随机分为两组,分别接受瑞芬太尼和丙泊酚的全静脉麻醉(TIVA组)或七氟醚 - 芬太尼麻醉(SF组)。TIVA组患者静脉注射丙泊酚1.5mg/kg和瑞芬太尼0.5μg/kg进行诱导。麻醉维持采用丙泊酚100μg/kg/min和瑞芬太尼0.0625 - 0.25μg/kg/min持续输注。SF组诱导时静脉注射芬太尼2μg/kg,随后静脉注射丙泊酚1.5mg/kg。维持麻醉采用1至1.5倍最低肺泡浓度的七氟醚,并根据需要静脉注射芬太尼1μg/kg。
两组患者的早期恢复时间(睁眼、对指令的反应、拔管、定向力、术后在手术室停留时间以及Aldrete评分≥9)和患者满意度相似。TIVA组达到麻醉后出院评分系统(PADSS)≥9的时间显著更短(135.9±51分钟 vs. 103±32分钟)(p<0.01),但这种差异与麻醉后恢复室(PACU)停留时间缩短无关。
全静脉麻醉和基于七氟醚的麻醉在早期恢复时间方面相当。尽管TIVA组患者达到出院标准的时间明显更短,但该技术并未缩短PACU停留时间,PACU停留时间反而取决于多个非医疗和管理问题。